Verrill Welcomes Health Care Attorney Alicia Siani

February 2, 2021 Press Releases

(February 2, 2021) – Verrill is pleased to welcome health care attorney Alicia Siani to the firm’s Boston, Massachusetts office. Siani represents clients in a wide range of regulatory issues, including HIPAA privacy matters, the Stark Law and Anti-Kickback Statute, licensing and certification, and fraud and abuse issues and investigations.

Michael Fee, Chair of Verrill’s Health Care and Life Sciences Practice said “We are very excited to add Alicia to our nationally-recognized health care and life sciences practice. Alicia brings with her a stellar academic record and a wealth of experience, particularly in health care policy and advocacy. A former participant in Verrill’s summer associate program, Alicia instantly became a substantial contributor to our work, advising health care and life sciences clients on issues of great importance, including HIPAA privacy, reimbursement and medical device regulation.”

Prior to joining Verrill, Siani served as Manager of the Health Reform Initiative at a Chicago-based maternal and child health nonprofit. In that role, she co-chaired the Governor’s Council for Early Learning SIAC Health subcommittee and conceptualized policies to improve access to comprehensive coverage under Illinois’ Medicaid Managed Care program. She also previously served as the health and education legislative assistant for U.S. Representative Rush D. Holt (NJ-12). During law school, she interned with the Health Law Advocates and Community Catalyst, as well as represented clients through Boston University’s Compassionate Release Practicum and Civil Litigation Clinic.

Siani received her bachelor’s degree from Davidson College, cum laude, and earned her law degree from the Boston University School of Law with a concentration in Health Law, magna cum laude.

Firm Highlights


Massachusetts Health Care Bill Makes Several Significant Changes

While you were celebrating the New Year, Governor Baker signed Chapter 260 of the Acts of 2020, an “Act promoting a resilient health care system that puts patients first,” the result of the Legislature’s...


Common Rule

Guided multiple clients through the implementation of the revised HHS regulations (the "Common Rule"), including reviewing and revising policies and procedures, and assisting with institutional approaches to implementation.


HHS Confirms Providers’ Right to 340B Discount Pricing for Contract Pharmacies

As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver covered...


European Union GDPR—Institution

Counseled a preeminent health system and academic medical center on its compliance with the European Union General Data Protection Regulation (GDPR) in relation to its clinical and research activities, including its international research studies...


Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition.

Health care attorney Paul Shaw co-authored Fraud and Abuse Investigations Handbook for the Health Care Industry, Second Edition with Robert Griffith, published by the American Health Law Association (AHLA). Paul and Robert provide legal...


Verrill Welcomes Jeffrey A. Smagula, Experienced Health Care and Life Sciences Attorney, Former Health Plan Compliance Executive

(May 12, 2021) – Verrill is pleased to welcome Jeffrey A. Smagula to the firm’s Boston office as Counsel in its nationally recognized Health Care & Life Sciences Group. Jeff Smagula brings to Verrill...


Multi-Site Global Research

Developed and negotiated site and coordinating center agreements in connection with a multi-site, international, National Institutes of Health (NIH)-funded study, and advised on regulatory issues related to the conduct of the study and subsequent...


Conflicts of Interest

Reviewed medical center's systems, policies and procedures for identifying, assessing, and managing investigator and institutional conflicts of interest.


The Regulatory Sprint is Over - What’s at the Finish Line Under the New Stark and AKS Final Rules?

The U.S. Department of Health and Human Services (HHS) completed its “Regulatory Sprint” by finalizing changes to regulations pertaining to two federal fraud and abuse laws. On December 2, 2020, the Centers for Medicare...


340B Providers Get Partial Relief from New Dispute Resolution Regulation

1. 340B ADR Process Established At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical manufacturers...

Contact Verrill at (855) 307 0700